DOSE-RANGING PAEDIATRIC STUDY: IDENTIFICATION OF A NOVEL MF59-ADJUVANTED 2A2B QUADRIVALENT INFLUENZA VACCINE

ESPID Education, Timo Vesikari, 7747

IMPACT OF VACCINATION WITH RIX4414 ON ROTAVIRUS GASTROENTERITIS (RVGE) IN CHILDREN AGED < 5 YEARS IN AUSTRALIA

ESPID Education, MAJA GALIC, 7959

TIMELINESS AND COMPLIANCE OF ROTAVIRUS VACCINATION IN AUSTRALIA

ESPID Education, MAJA GALIC, 7958

DETECTION OF FUSOBACTERIAL INFECTION IN A CULTURE-NEGATIVE BRAIN ABSCESS WITH 16S rRNA GENE PCR

ESPID Education, Christina Kortsalioudaki, 7957

IMMUNOGLOBULIN DEFICIENCY IN CHILDREN WITH HIB VACCINE FAILURE

ESPID Education, Clarissa Oeser, 7955

HOSPITALIZED CHILDHOOD COMMUNITY ACQUIRED PNEUMONIA (CAP) IN BELGIUM: PNEUMOCOCCAL ETIOLOGY AND SEROTYPE DISTRIBUTION BASED ON CULTURE AND SEROTYPE SPECIFIC SEROLOGY.

ESPID Education, Iris De Schutter, 7799

DEVELOPMENT OF A RAPID METHOD FOR IDENTIFICATION AND QUANTITATION OF PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES

ESPID Education, Manoj Kumar, 7797

LIMITED IMPACT OF THE 7-VALENT PNEUMOCOCCAL VACCINE ON PAEDIATRIC EMPYEMA IN THE NORTH OF ENGLAND

ESPID Education, Mohamed Elemraid, 7795

HIGHER STAPHYLOCOCCUS AUREUS COLONIZATION IN 11-MONTH-OLD CHILDREN FOLLOWING PCV-7 VACCINATIONS IN INFANCY

ESPID Education, S.M.P.J. Prevaes, 7794

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN CHILDREN PREVIOUSLY PARTIALLY IMMUNIZED WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7): PHASE 3, OPEN-LABEL TRIAL

ESPID Education, Sven-Arne Silfverdal, 7793

EFFECTS OF SIMPLIFICATION OF HAART IN HIV INFECTED CHILDREN

ESPID Education, Mar Santos-Sebastián, 7792

NORMAL BONE MINERAL CONTENT AMONG HIV-UNINFECTED CHILDREN PERINATALLY EXPOSED TO ANTIRETROVIRALS

ESPID Education, Rosa Pino Ramírez, 7791

HIGH PREVALENCE OF LOW VITAMIN D IN HIV VERTICALLY INFECTED CHILDREN LIVING IN IRELAND

ESPID Education, Patrick Gavin, 7790

IMPROVING ANTIRETROVIRAL THERAPY ADHERENCE IN HIV-INFECTED CHILDREN. PILOT STUDY.

ESPID Education, Fernando Moraga-Llop, 7789

HIV CHARACTERISTICS AND EDUCATIONAL ACHIEVEMENT OF A COHORT OF HIV INFECTED ADOLESCENTS DUE TO VERTICAL TRANSMISSION.

ESPID Education, María González Tomé, 7788

CHARACTERISTICS OF CHILDREN BORN TO HIV-INFECTED MOTHERS IN EQUATORIAL GUINEA

ESPID Education, katie badillo, 7787

IMPAIRED T-CELL DEPENDENT AND INDEPENDENT MEMORY B-CELL FORMATION IN HIV-INFECTED CHILDREN

ESPID Education, D. van den Heuvel, 7786

LONG-TERM RESPONSE TO HEPATITIS B VIRUS VACCINATION IN HIV-INFECTED CHILDREN; IMPLICATIONS OF HAART INTERRUPTION

ESPID Education, Antoni Noguera-Julian, 7785

GENOTYPE DISTRIBUTION AND ROTAVIRUS GASTROENTERITIS HOSPITALIZATIONS FOUR YEARS AFTER VACCINATION IN SAO PAULO, BRAZIL

ESPID Education, Marco Safadi, 7784

EPIDEMIOLOGY OF THE UNVACCINATED: A BEHAVIOUR CHANGE COMMUNICATIONS FRAMEWORK AND TOOLKIT FOR THE WHO EUROPEAN REGION.

ESPID Education, Robb Butler, 7780

VACCINE UPTAKE DETERMINANTS IN THE NETHERLANDS

ESPID Education, Hester de Melker, 7779

SPECIAL IMMUNIZATION SERVICE (SIS) IN PADOVA: 8 YEARS OF EXPERIENCE

ESPID Education, Teresa Mion, 7778

SYNCOPE IN MASS VACCINATION CAMPAIGNS IN THE NETHERLANDS; MENC IN 2002, HPV IN 2009, H1N1 IN 2009

ESPID Education, Patricia Vermeer-de Bondt, 7777

MAINTENNANCE OF IMMUNE RESPONSE THROUGHOUT CHILDHOOD FOLLOWING SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINATION IN EARLY CHILDHOOD

ESPID Education, Ameneh Khatami, 7771

THE B-CELL RESPONSE TO PRIMARY AND BOOSTER DOSES OF MENACWY‑CRM VACCINE ADMINISTERED AT 2, 4 AND 12 MONTHS OF AGE

ESPID Education, Geraldine Blanchard-Rohner, 7769

'DECLINE OF IgG-PERTUSSIS TOXIN IN UMBILICAL CORD BLOOD AND NEONATAL SERUM'

ESPID Education, N.A. van Welie, 7768

PERTUSSIS AFTER END OF A MASS VACCINATION PROJECT - END OF THE VACCINATION HONEY- MOON

ESPID Education, Birger Trollfors, 7767

BACTERIAL CELL WALL COMPONENT MURAMYL DIPEPTIDE SYNERGIZES WITH RESPIRATORY SYNCYTIAL VIRUS IN CYTOKINE PRODUCTION

ESPID Education, Marloes Vissers, 7766

A PRACTICAL APPROACH TO Q FEVER IN CHILDREN

ESPID Education, Ingeborg Bart, 7735

Q FEVER IN THE NETHERLANDS IS LESS REPORTED IN CHILDREN

ESPID Education, Edwin Slok, 7736

DISTRIBUTION BY CLINICAL PRESENTATION OF SEROTYPES ISOLATED FROM PEDIATRIC INVASIVE PNEUMOCOCCAL DISEASES IN 2009-2010 IN MADRID, SPAIN

ESPID Education, Jesus Ruiz-Contreras, 7737

CROSS-SECTIONAL POPULATION-BASED STUDY TO EVALUATE THE SEROPREVALENCE OF 13 SEROTYPE SPECIFIC IGG ANTIBODIES AGAINST STREPTOCOCCUS PNEUMONIAE

ESPID Education, Karin Elberse, 7738

FALL OR SPRING FOR PNEUMOCOCCUS? CHANGES IN INVASIVE PNEUMOCOCCAL DISEASE IN SPANISH CHILDREN

ESPID Education, Fernando Moraga-Llop, 7739

PNEUMOCOCCAL SEROTYPES IN COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN VACCINATED WITH PCV-7

ESPID Education, Josette Raymond, 7740

SEROTYPE DISTRIBUTION AND SENSIVITY TO PENICILLIN OF STREPTOCOCCUS PNEUMONIAE ISOLATES THAT CAUSE INVASIVE DISEASE AMONG BRAZIL CHILDREN.

ESPID Education, Cristina Yoshioka, 7741

EXPECTED IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN INVASIVE BACTERIAL INFECTION RATE IN THE PEDIATRIC EMERGENCY DEPARTMENT

ESPID Education, Borja Gómez, 7742

SURVEILLANCE OF VIRAL RESPIRATORY INFECTIONS IN THE EMERGENCY DEPARTMENT USING MICROARRAYS

ESPID Education, Sophia Kouni, 7764

CLINICAL CHARACTERISTICS OF SWINE FLU (H1N1) COMPARED TO OTHER RESPIRATORY VIRUSES IN THE UNITED KINGDOM

ESPID Education, Jesal Patel, 7746

SHOCK AND HIGH MORTALITY IN “THIRD WAVE” INFLUENZA A H1N1/09 INTENSIVE CARE ADMISSIONS

ESPID Education, Stuart Gormley, 7968

MF59®-ADJUVANTED H1N1 VACCINES IN CHILDREN 3-17 YEARS: SAFETY AND IMMUNOGENICITY FOLLOWING A 1-YEAR BOOSTER VACCINATION

ESPID Education, Maria Lattanzi, 7748

ANTIBODY PERSISTENCE IN CHILDREN VACCINATED WITH ONE DOSE OF ASO3-ADJUVANTED A/H1N1/2009 VACCINE AND THE EFFECT OF SEASONAL 2010-2011 INFLUENZA VACCINE

ESPID Education, Vladimir Gilca, 7749

IMMUNOGENICITY AND SAFETY OF INTRADERMAL INFLUENZA VACCINES WITH DIFFERENT AMOUNT OF ANTIGENS IN OTHERWISE HEALTHY CHILDREN

ESPID Education, Susanna Esposito, 7751

SAFETY OF A THREE SUBUNIT INFLUENZA VACCINE IN HEALTH CARE WORKERS IN KURDISTAN: A CROSS SECTIONAL STUDY

ESPID Education, Jafar Soltani, 7752

ACUTE GASTROENTERITIS HOSPITALIZATIONS BEFORE AND AFTER ROTAVIRUS VACCINE INTRODUCTION IN NORTH-WEST SPAIN (GALICIA).

ESPID Education, Federico Martinón-Torres, 7756

IMPACT OF A ROTAVIRUS VACCINATION CAMPAIGN ON HOSPITALISATIONS IN FRANCE : THIRD -YEAR SURVEY OF THE IVANHOE STUDY

ESPID Education, Arnaud Gagneur, 7758

THE BURDEN OF ROTAVIRUS DISEASE IN DENMARK 2009-2010

ESPID Education, Claus Sixtus Jensen, 7760

LENGTH OF HOSPITAL STAY FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) IN PROPHYLAXED VERSUS NON-PROPHYLAXED PREMATURE INFANTS

ESPID Education, Katharina Büsch, 7762

EFFECT OF INHALED HYPERTONIC SALINE SOLUTION TO TREAT INFANTS HOSPITALIZED WITH VIRAL BRONCHIOLITIS

ESPID Education, Anne Hochs, 7763

PROSPECTIVE, MULTINATIONAL ACTIVE HOSPITAL-BASED EPIDEMIOLOGIC SURVEILLANCE FOR IPD AND PNEUMONIA BURDEN AMONG CHILDREN IN BANGALORE SOUTH ZONE, BANGALORE, INDIA

ESPID Education, Ramalinge Gowda Nisarga, 7743

BUILDING UP AN EVIDENCE BASE FOR SUPPORTING HARMONISATION OF IMMUNISATION SCHEDULES IN EUROPE

ESPID Education, Pier Luigi Lopalco, 4855

DIFFICULTIES OF EMEA FOR REGISTRATION INDUCED BY THE DIFFERENT SCHEDULES IN EUROPE

ESPID Education, Pieter Neels, 4854

INFANT VACCINE SCHEDULES: MAY VACCINE IMMUNOLOGY SHOW US THE WAY FORWARD?

ESPID Education, Claire-Anne Siegrist, 4853

CHILDREN WITH FEVER WITHOUT SOURCE: LOOKING FOR THE MARKER

ESPID Education, Octavio Ramilo, 4851

INTERPRETATION OF A SINGLE LABORATORY TEST TO DISCRIMINATE BETWEEN VIRAL AND BACTERIAL INFECTIONS IN CHILDREN WITH FEVER WITHOUT SOURCE?

ESPID Education, Alain Gervaix, 4849

DIAGNOSTIC VALUE OF SYMPTOMS AND SIGNS IN ASSESSING THE RISK FOR SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH FEVER WITHOUT SOURCE

ESPID Education, Matthew Thompson, 4848

CHILDREN WITH FEVER: CHALLENGES FOR PAEDIATRICIANS AND METHODOLOGISTS

ESPID Education, Rianne Oostenbrink, 4847

HOW TO MANAGE RESISTANT GRAM+ ORGANISM INFECTIONS IN CHILDREN?

ESPID Education, Faculty / Presenters, 4845

COLIMYCIN

ESPID Education, Robert Cohen, 4844

PENEMS

ESPID Education, Xavier Durrmeyer, 4843

DAPTOMYCIN

ESPID Education, Christian Chidiac, 4842

NEW AND OLD ANTIBIOTICS TO TREAT RESISTANT BACTERIA: LINEZOLID

ESPID Education, Celine Pulcini, 4841

Clinical Cases

ESPID Education, Emmanuel Grimprel, 5244

Expecting a baby... at home or abroad?

ESPID Education, Catherine Weil-Olivier, 5245

IMMUNIZATION IN SPECIAL CIRCUMSTANCES: FROM GUIDELINES TO PATIENT CARE, THE INFOVAC EXPERT NETWORK MODEL

ESPID Education, Claire-Anne Siegrist, 4840

Rare and not so rare! Do I know?

ESPID Education, Ulrich Heininger, 5243

HOW TO MANAGE RESISTANT GRAM- ORGANISM INFECTIONS IN CHILDREN?

ESPID Education, Shai Ashkenazi and Edouard Bingen , 4838

Immunity or autoimmunity? This is often the question!

ESPID Education, Claire-Anne Siegrist, 5246

INFECTIONS IN PATIENTS ON THE NEW BIOLOGICAL IMMUNOSUPPRESSIVE AGENTS

ESPID Education, Mario Abinun, 4837

DIAGNOSIS & MANAGEMENT OF INFECTIONS IN CHILDREN WITH IMMUNE DEFICIENCIES

ESPID Education, Andrew Cant, 4836

INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN: A PRIMARY IMMUNODEFICIENCY ?

ESPID Education, Capucine Picard, 4835

MDR-TB MANAGEMENT IN A 7-MONTH-OLD CHINESE GIRL

ESPID Education, Luis Gonzalez-Granado, 3700

CASE HSV-Neonate

ESPID Education, Michael Buettcher, 3701

RECIDIVANT NEONATAL ESCHERICHIA COLI MENINGITIS

ESPID Education, Anja Radsel, 3702

CENTRAL VENOUS CATHETERS-RELATED INFECTIONS

ESPID Education, Simone Cesaro, 3568

THE APPROACH TO A CHILD WITH NEUTROPENIC FEVER

ESPID Education, Itzhak Levy, 3567

TREATING SEVERE STAPHYLOCOCCAL INFECTIONS

ESPID Education, Sheldon Kaplan, 3566

INTRODUCTION AND AIM OF THE WORKSHOP

ESPID Education, Carlo Giaquinto, 3564